Skip to main content
. 2016 Aug 31;8(9):81. doi: 10.3390/cancers8090081

Figure 2.

Figure 2

FDG-PET/CT images before (A and C) and 4 weeks after (B and D) 90Y-microsphere radioembolisation in liver-dominant mCRC; (A and B) The illustrated metabolic response was associated with a survival of 12 months after treatment; (C and D) This metabolic non-responder survived 5 months after treatment. Figure reproduced with permission from Sabet et al. [35].